| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 10, 2026
More than 23 procedures performed across seven sites in Germany, the United Kingdom, Italy, and Spain
-
Sep 3, 2026
Following recent U.S. Food and Drug Administration (FDA) labeling approval, European label milestone reinforces Medtronic leadership in advancing aortic care based on clinical evidence supporting the treatment of ruptured abdominal aortic aneurysms (rAAA).
-
Apr 29, 2026
Recognition highlights Medtronic as a leading workplace for career growth across key European markets
-
Nov 10, 2025
Confirmation comes from the position paper published by the Italian Society of Nephrology (SIN), expanding the indication of RDN to a complex and high-risk patient population
-
Oct 13, 2024
Funding to support organisations with a mission to improve health outcomes
-
Oct 5, 2023
Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.
-
Apr 27, 2022
Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
-
Apr 25, 2022
Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
-
Apr 20, 2022
Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...